Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

Introduction: This double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous epoetin alfa-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease (ESKD) and anemia who were receiving epoetin a...

Full description

Bibliographic Details
Main Authors: Steven Fishbane, Bruce S. Spinowitz, Wayne A. Wisemandle, Nancy E. Martin
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024919302050

Similar Items